COSCIENS Biopharma Inc. Current Trade Receivables
COSCIENS Biopharma Inc. (CSCIF) had Current Trade Receivables of $1.08 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Receivables
ifrs-full:CurrentTradeReceivables · last filed 2026-03-25
- 2025-12-31: Current Trade Receivables $1.08M.
- 2024-12-31: Current Trade Receivables $1.88M.
- 2023-12-31: Current Trade Receivables $126.00K; Current Trade Receivables as first filed $67.00K.
- 2022-12-31: Current Trade Receivables $403.00K.
| Period end | Current Trade Receivables | Current Trade Receivables as first filed |
|---|---|---|
| 2025-12-31 | $1.08M 20-F · filed 2026-03-25 | |
| 2024-12-31 | $1.88M 20-F · filed 2026-03-25 | |
| 2023-12-31 | $126.00K 20-F · filed 2025-04-09 | $67.00K 20-F · filed 2024-03-27 |
| 2022-12-31 | $403.00K 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $383.00K 6-K · filed 2022-11-03 | |
| 2022-06-30 | $490.00K 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $302.00K 6-K · filed 2022-05-11 | |
| 2021-12-31 | $877.00K 20-F/A · filed 2024-02-15 | |
| 2021-09-30 | $459.00K 6-K · filed 2021-11-04 | |
| 2021-06-30 | $1.01M 6-K · filed 2021-08-05 | |
| 2021-03-31 | $554.00K 6-K · filed 2021-05-05 | |
| 2020-12-31 | $1.19M 20-F · filed 2022-03-29 | |
| 2020-09-30 | $61.00K 6-K · filed 2020-11-05 | |
| 2020-06-30 | $121.00K 6-K · filed 2020-08-06 | |
| 2020-03-31 | $161.00K 6-K/A · filed 2020-05-11 | |
| 2019-12-31 | $210.00K 40-F/A · filed 2021-03-29 | |
| 2019-09-30 | $256.00K 6-K · filed 2019-11-07 | |
| 2019-06-30 | $217.00K 6-K · filed 2019-08-13 | |
| 2018-12-31 | $142.00K 20-F · filed 2020-03-31 | |
| 2017-12-31 | $20.00K 20-F · filed 2019-04-01 | |
| 2016-12-31 | $155.00K 20-F · filed 2018-03-28 |